Richard Norton’s death was triggered by an unauthorized peptide injection he administered in excess of his prescribed dose, a coroner has ruled.
The Australian actor and stuntman, 75, died at Melbourne’s Alfred Hospital on March 30 last year after injecting himself with CJC1295/Ipamorelin, a combination typically promoted for muscle growth, weight loss and recovery enhancement. Coroner David Ryan delivered his findings 19 months after Norton’s passing, determining the injection caused a fatal anaphylactic reaction that led to cardiac arrest.
“I am satisfied that Richard’s death was triggered by his injection of the peptide CJC1295/Ipamorelin,” Ryan wrote in his report. “Richard had been taking amounts of the medication in excess of the dose prescribed by his medical practitioner.”
The coroner noted that Norton had signed an informed consent form and was informed of the experimental nature of the peptide treatment. Ryan’s report also revealed Norton had previously been prescribed peptides by another practitioner, which the actor said had been effective in treating symptoms relating to fatigue, reduced physical recovery, shoulder pain and loss of lean muscle mass.
The fatal sequence began on March 28 last year, when Norton told a nurse he had been taking more than his prescribed dose of peptides. The nurse instructed him to follow the correct dosage. Hours later, Norton felt hot and flushed and became unresponsive. He died in hospital shortly afterward.
Ryan has recommended Australia’s Therapeutic Goods Administration re-examine the drugs. “I am not satisfied that it is appropriate for them to be available to be prescribed by medical practitioners,” the coroner stated. “It is not clear to me how their safe use can be clinically indicated given the acknowledged uncertainties as to their therapeutic benefit and their risks (as yet not fully known) to the safety of patients.”
Norton built a career working alongside major Hollywood stars including Margot Robbie, Ben Affleck and Liam Neeson across various film projects. His death has intensified scrutiny of peptide availability in Australia, with some coverage noting the country may move to restrict the substances following the coroner’s findings.
CJC-1295 and Ipamorelin function by stimulating the body’s natural production of growth hormones, according to health experts, though their therapeutic benefits and safety profiles remain subjects of ongoing debate.
Ryan continued in his report: “He disclosed… That he had been previously prescribed peptides by another practitioner which had been effective in treating symptoms relating to fatigue, reduced physical recovery, shoulder pain and loss of lean muscle mass.”
The coroner has formally urged regulatory review of whether such peptides should remain accessible through medical prescription given the unresolved questions surrounding their clinical value and patient safety.